HLA-A*0201 + Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HLA-A*0201 + Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients

Published:2012-10 Issue:10 Volume:132 Page:2395-2406
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Aspord Caroline,Leccia Marie-Therese,Salameire Dimitri,Laurin David,Chaperot Laurence,Charles Julie,Plumas Joel

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference48 articles.

1. Plasmacytoid dendritic cell precursors induce allogeneic T cell hyporesponsiveness and prolong heart graft survival;Abe;Am J Transplant,2005

2. A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells;Aspord;PLoS One,2010

3. Induction of anti-viral cytotoxic T cells by plasmacytoid dendritic cells for adoptive immunotherapy of post-transplant diseases;Aspord;Am J Transplant,2011

4. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells;Chaperot;J Immunol,2006

5. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling;Journal of Experimental & Clinical Cancer Research;2024-07-17

2. Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell–Based Approach for the Expansion and Characterization of SARS-CoV-2–Specific T Cells;The Journal of Immunology;2024-02-02

3. Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift;Frontiers in Immunology;2024-01-03

4. Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities;Current Treatment Options in Oncology;2023-11-14

5. Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation;Cancers;2023-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3